Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

K Welte(Memorial Sloan Kettering Cancer Center), M A Moore(Memorial Sloan Kettering Cancer Center), Li Lu(Guangdong Pharmaceutical University), E Platzer(Friedrich-Alexander-Universität Erlangen-Nürnberg), J. Lester Gabrilove(Memorial Sloan Kettering Cancer Center), Roland Mertelsmann(Twitter (United States)), E. Levi(Memorial Sloan Kettering Cancer Center)
Proceedings of the National Academy of Sciences
March 1, 1985
10.1073/pnas.82.5.1526
Cited by 522

Related Papers

Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia
|Cell|1997|1.5k
Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells
|Science|1986|1.2k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology
|Annals of Hematology|2004|488
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
|Blood|1994|431